Cancer Pharmacokinetics Research Specialist

NIH RePORTER · NIH · R50 · $182,510 · view on reporter.nih.gov ↗

Abstract

Summary The long-term goal of this application is to provide stable research funding for a Cancer Pharmacokinetics Research Specialist within the UPMC Hillman Cancer Center (HCC) Cancer Pharmacokinetics and Pharmacodynamics Facility (CPPF). The activities of the Cancer Pharmacokinetics Research Specialist can be categorized broadly into: (1) Preclinical cancer research; and (2) Clinical cancer research. The Cancer Pharmacokinetics Research Specialist plays an absolutely critical role in developing and validating novel LC-MS/MS methodologies, and applying them to precisely delineate the PK and metabolism of novel and established agents. The Research Specialist's career goals are to expand his armamentarium by completing the CPPF instrument upgrade; to expand his skill-set by taking training and courses on the new instruments and software and cross-train CPPF personnel; thereby maximizing utilization of novel instruments, which is sure to enhance the research output of the CPPF. This award will allow the CPPF Cancer Pharmacokinetics Research Specialist to continue to be at the cutting edge, with the ultimate aim of serving the scientific community in early drug development needs.

Key facts

NIH application ID
10312236
Project number
2R50CA211241-06
Recipient
UNIVERSITY OF PITTSBURGH AT PITTSBURGH
Principal Investigator
Robert Parise
Activity code
R50
Funding institute
NIH
Fiscal year
2021
Award amount
$182,510
Award type
2
Project period
2016-09-15 → 2026-08-31